Staff Profile

Prof Sebastian Brandner

Photo

Personal Profile

Name: Sebastian Brandner Email: s.brandner@ucl.ac.uk
Title: Prof Tel: 020 3448 4435
Department: Neurodegenerative Diseases Fax: 020 3448 4486
Position: Professor of Neuropathology Address: Institute of Neurology , UCL, Queen Square House, London , WC1N 3BG
Research Domain: Cancer, Neuroscience Web Page: Personal Web Page

Profile

Research Description

Modelling intrinsic brain tumours: Oncogenic signalling in neural stem cells

Intrinsic benign and malignant brain tumours, such as astrocytomas and glioblastoma are thought to originate from a population of stem cells in the adult brain. Stem cells divide in the adult brain to form more mature cells such as nerve cells (neurones) astrocytes (supporting cells) or oligodendrocytes (myelin forming cells that wrap processes of neurones in the white matter). We are working on the mechanisms of how mutations in genes that control cell division and migration of stem cells can cause brain tumours.

A novel aspect of our work is that the type of tumours depends on the pattern of mutations in stem cells, even when mutated stem cells are taken away from their normal environment and are placed in other areas of the brain. Knowledge of this mechanism is an important step towards the understanding where brain tumours originate from and how a certain type of brain tumour forms. 

How does the model work?

We inactivate tumour suppressor genes (PTEN, RB, p53) in the neural stem cell compartment. By injecting Cre-expressing virus into the ventricles of conditional knockout mice (PTENlox/lox, p53lox/lox and Rblox/lox in various combinations) the targeted genes are recombined only in cells located near the sub-ventricular zone (SVZ) which contains the largest known population of neural stem cells. In mice where Rb and p53, or the trio of the genes, PTEN, P53 and Rb are recombined, after several months, tumours of a specific phenotype resembling that of a human PNET develop. Instead, a tumour resembling human glioma (similar to oligoastrocytomas) is induced in mice where PTEN and P53 are targeted

Several weeks to months prior to the development of large tumours, small neoplastic lesions can be observed which we call microneoplasia. The assumption is that during the considerable time it takes to develop evident tumours additional genetic lesions are accumulated on top of the ones induced by Cre-recombination 








Research Activities

Glial development in the PNS

Investigating the molecular basis of frontotemporal dementia

Neural stem cells and brain tumours

Neuropathology of Stem Cells in Children

Perinatal Neuroscience

The neurogenetics of neurodegenerative disease

Education Description

I actively contribute to capacity building in my role as educational supervisor for neuropathology trainees. I am advisor for training programmes at the London Deanery and contribute to training schemes in neuropathology. As chair of the academic group in the British Neuropathology Society (BNS) I organised a stimulating summer school (2009 & 2011) to bring together clinical scientists, neuropathology and neurology trainees.

I am Module Editor for the Module Neuro-Oncology in the DOH e-Learning for health
programme, an on-line resource of healthcare professionals which is now successfully completed.

Taught Courses: 

  • MSc students (2 Neuroscience and 1 Neuroradiology 

    modules)
  • Medical students 2nd and 3rd year:
  • Clinical Neuropathology
  • Clinical pathological conferences, seminars, courses.
  • Invited lectures in several UK Universities
  • Editorial team Queen Square Text book
  • Committee member North Thames Deanery Histopathology, STA, UCL College representative 



Excellent feedback results from students: 
  • Excellent feedback from UCL MSc courses (scores 4&5 of 5 in survey)

 Feedback from my lectures (UCL) reads as follows (e.g in 2010): “Prof 

Brandner’s lectures were the highlight of this pathology week.  They were 

engaging and interesting, balancing facts with background information, and his 

PowerPoint presentation was superbly structured and easy to follow with clear diagrams and excellent explanations of all that he had included.  The poster sessions were a good way of consolidating knowledge and Prof Brandner was extremely approachable to answer questions 



UCL Collaborators

Prof Gennadij Raivich; Prof Faraneh Vargha-Khadem; Prof Clare Futter; Prof John Hardy; Prof Nikki Robertson; Dr Tom Jacques; Prof Donald Peebles; Dr Robin Ketteler; Prof Elizabeth Fisher; Prof Kristjan Jessen; Prof Rhona Mirsky; Prof Mark Marsh; Prof Michael Duchen; Prof Mary Reilly; Prof Patrick Anderson; Dr Adrian Isaacs; Prof Tamas Revesz; Prof Martin Rossor; Prof Linda Greensmith; Prof Martin Koltzenburg; Prof Steve Hunt; Prof Francesco Muntoni; Prof Nick Fox

External Collaborators

Prof Terje Johansen; Dr Anne Simonsen; Freja Consortium; Prof Christine Van Broeckhoven

Publications

    2013

    • Marquez-Infante C, Murphy SM, Mathew L, Alsanousi A, Lunn MP, Brandner S, Yousry TA, Blake J, Reilly MM (2013). Asymmetric sensory ganglionopathy: A case series. Muscle and Nerve, , - .
    • Osellame LD, Rahim AA, Hargreaves IP, Gegg ME, Richard-Londt A, Brandner S, Waddington SN, Schapira AHV, Duchen MR (2013). Mitochondria and quality control defects in a mouse model of Gaucher disease - links to Parkinson’s Disease. Cell Metabolism, , - .
    • Reiniger L, Mirabile I, Lukic A, Linehan J, Groves M, Rudge P, Collinge J, Mead S, Brandner S (2013). Filamentous white matter prion protein deposition is a distinctive feature of multiple inherited prion diseases.
    • Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, Grose R, Jones C, Salomoni P (2013). The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.. Oncogene, 32(6), 699 - 712. doi:10.1038/onc.2012.111
    • Akhtar S, Grizenkova J, Wenborn A, Hummerich H, Fernandez de Marco M, Brandner S, Collinge J, Lloyd SE (2013). Sod1 deficiency reduces incubation time in mouse models of prion disease.. PLoS One, 8(1), e54454 - . doi:10.1371/journal.pone.0054454
    • Acquati S, Greco A, Licastro D, Bhagat H, Ceric D, Rossini Z, Grieve J, Shaked-Rabi M, Henriquez NV, Brandner S, Stupka E, Marino S (2013). Epigenetic regulation of survivin by Bmi1 is cell type specific during corticogenesis and in gliomas.. Stem Cells, 31(1), 190 - 202. doi:10.1002/stem.1274
    • Cottenie E, Menezes MP, Rossor AM, Morrow JM, Yousry TA, Dick DJ, Anderson JR, Jaunmuktane Z, Brandner S, Blake JC, Houlden H, Reilly MM (2013). Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy.. Neuromuscul Disord, 23(5), 399 - 403. doi:10.1016/j.nmd.2013.01.010

    2012

    • Watts C, Brandner S (2012). Emerging Concepts in Neuro-Oncology.
    • Grizenkova J, Akhtar S, Hummerich H, Tomlinson A, Asante E, Wenborn A, Fizet J, Poulter M, Wiseman F, Fisher EMC, Tybulewicz V, Brandner S, Colllinge J, Lloyd S (2012). Over-expression of Hspa13 (Stch) reduces prion disease incubation time in mice. Proc Natl Acad Sci U S A, 09(34):13722-7. Epub 2012 Aug 6, - .
    • Jaffer F, Murphy SM, Scoto M, Healy E, Rossor AM, Brandner S, Phadke R, Selcen D, Jungbluth H, Muntoni F, Reilly MM (2012). BAG3 mutations: another cause of giant axonal neuropathy.. J Peripher Nerv Syst, 17(2), 210 - 216. doi:10.1111/j.1529-8027.2012.00409.x
    • Hyare H, Ramlackhansingh A, Gelosa G, Edison P, Rudge P, Brandner S, Brooks DJ, Collinge J, Mead S (2012). C-11-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 83(3), 340 - 341.
    • Ghazi-Noori S, Froud KE, Mizielinska S, Powell C, Smidak M, Fernandez de Marco M, O'Malley C, Farmer M, Parkinson N, Fisher EM, Asante EA, Brandner S, Collinge J, Isaacs AM (2012). Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice.. Brain, 135(Pt 3), 819 - 832. doi:10.1093/brain/aws006
    • Davidson G, Murphy S, Polke J, Laura M, Salih M, Muntoni F, Blake J, Brandner S, Davies N, Horvath R, Price S, Donaghy M, Roberts M, Foulds N, Ramdharry G, Soler D, Lunn M, Manji H, Davis M, Houlden H, Reilly M (2012). Frequency of mutations in the genes associated with hereditary sensory and autonomic neuropathy in a UK cohort.. J Neurol, 259(8), 1673 - 1685. doi:10.1007/s00415-011-6397-y
    • Murphy SM, Davidson GL, Brandner S, Houlden H, Reilly MM (2012). Mutation in FAM134B causing severe hereditary sensory neuropathy.. J Neurol Neurosurg Psychiatry, 83(1), 119 - 120. doi:10.1136/jnnp.2010.228965
    • Klöhn PC, Farmer M, Linehan JM, O'Malley C, Fernandez de Marco M, Taylor W, Farrow M, Khalili-Shirazi A, Brandner S, Collinge J (2012). PrP antibodies do not trigger mouse hippocampal neuron apoptosis.. Science, 335(6064), 52 - . doi:10.1126/science.1215579
    • Kloehn P, Castro-Seoane R, Hummerich H, Sweeting T, Tattum H, Linehan J, de Marco MF, Brandner S, Collinge J (2012). Plasmacytoid dendritic cells sequester high prion titers at early stages of prion infection. PRION, 6, 7 - 7.
    • Weis J, Brandner S, Lammens M, Sommer C, Vallat JM (2012). Processing of nerve biopsies: a practical guide for neuropathologists.. Clin Neuropathol, 31(1), 7 - 23.
    • Sheppard O, Plattner F, Rubin A, Slender A, Linehan JM, Brandner S, Tybulewicz VL, Fisher EM, Wiseman FK (2012). Altered regulation of tau phosphorylation in a mouse model of down syndrome aging.. Neurobiol Aging, 33(4), 828.e31 - 828.e44. doi:10.1016/j.neurobiolaging.2011.06.025
    • Zadeh G, Salehi F, An S, Uff C, Camp S, Revesz T, Holton J, Thom M, McEvoy AW, Grieve J, Kitchen N, Brandner S (2012). Diagnostic implications of histological analysis of neurosurgical aspirate in addition to routine resections.. Neuropathology, 32(1), 44 - 50. doi:10.1111/j.1440-1789.2011.01234.x
    • Hyare H, Ramlackhansingh A, Gelosa G, Edison P, Rudge P, Brandner S, Brooks DJ, Collinge J, Mead S (2012). 11C-PiB PET does not detect PrP-amyloid in prion disease patients including variant Creutzfeldt-Jakob disease.. J Neurol Neurosurg Psychiatry, 83(3), 340 - 341. doi:10.1136/jnnp.2010.233692
    • Castro-Seoane R, Hummerich H, Sweeting T, Tattum MH, Linehan JM, Fernandez de Marco M, Brandner S, Collinge J, Klöhn PC (2012). Plasmacytoid dendritic cells sequester high prion titres at early stages of prion infection.. PLoS Pathog, 8(2), e1002538 - . doi:10.1371/journal.ppat.1002538

    2011

    • Banks GT, Haas MA, Line S, Shepherd HL, Alqatari M, Stewart S, Rishal I, Philpott A, Kalmar B, Kuta A, Groves M, Parkinson N, Acevedo-Arozena A, Brandner S, Bannerman D, Greensmith L, Hafezparast M, Koltzenburg M, Deacon R, Fainzilber M, Fisher EM (2011). Behavioral and other phenotypes in a cytoplasmic Dynein light intermediate chain 1 mutant mouse.. J Neurosci, 31(14), 5483 - 5494. doi:10.1523/JNEUROSCI.5244-10.2011
    • Sadnicka A, Reilly MM, Mummery C, Brandner S, Hirsch N, Lunn MP (2011). Rituximab in the treatment of three coexistent neurological autoimmune diseases: chronic inflammatory demyelinating polyradiculoneuropathy, Morvan syndrome and myasthenia gravis.. J Neurol Neurosurg Psychiatry, 82(2), 230 - 232. doi:10.1136/jnnp.2009.174888
    • Thom M, Toma A, An S, Martinian L, Hadjivassiliou G, Ratilal B, Dean A, McEvoy A, Sisodiya SM, Brandner S (2011). One hundred and one dysembryoplastic neuroepithelial tumors: an adult epilepsy series with immunohistochemical, molecular genetic, and clinical correlations and a review of the literature.. J Neuropathol Exp Neurol, 70(10), 859 - 878. doi:10.1097/NEN.0b013e3182302475
    • Murphy SM, Davidson GL, Laura M, Salih MAM, Muntoni F, Lunn MP, Blake J, Bull K, Brandner S, Polke J, Davis M, Houlden H, Reilly MM (2011). GENETIC MUTATION FREQUENCY IN PATIENTS WITH HEREDITARY SENSORY AND AUTONOMIC NEUROPATHIES (HSAN).
    • Carswell C, Drynda R, Martins S, Clarke A, Brandner S, Mead S, Collinge J, Khalili-Shirazi A (2011). PAW35 Anti-prion protein monoclonal antibodies at low doses effectively treat prion disease in mice without side-effects (vol 81, pg e33, 2010). J NEUROL NEUROSUR PS, 82(7), 826 - 826. doi:10.1136/jnnp.2010.226340.63corr1
    • Kaski DN, Pennington C, Beck J, Poulter M, Uphill J, Bishop MT, Linehan JM, O'Malley C, Wadsworth JD, Joiner S, Knight RS, Ironside JW, Brandner S, Collinge J, Mead S (2011). Inherited prion disease with 4-octapeptide repeat insertion: disease requires the interaction of multiple genetic risk factors.. Brain, 134(Pt 6), 1829 - 1838. doi:10.1093/brain/awr079
    • Murphy SM, Polke J, Manji H, Blake J, Reiniger L, Sweeney M, Houlden H, Brandner S, Reilly MM (2011). A novel mutation in the nerve-specific 5'UTR of the GJB1 gene causes X-linked Charcot-Marie-Tooth disease.. J Peripher Nerv Syst, 16(1), 65 - 70. doi:10.1111/j.1529-8027.2011.00321.x
    • Saifee TA, Elliott KJ, Rabin N, Yong KL, D'Sa S, Brandner S, Lunn MP, Blake J, Reilly MM (2011). Bortezomib-induced inflammatory neuropathy (vol 15, pg 366, 2010). J PERIPHER NERV SYST, 16(1), 74 - 74. doi:10.1111/j.1529-8027.2011.00315.x
    • Wadsworth JD, Dalmau-Mena I, Joiner S, Linehan JM, O'Malley C, Powell C, Brandner S, Asante EA, Ironside JW, Hilton DA, Collinge J (2011). Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.. J Pathol, 223(4), 511 - 518. doi:10.1002/path.2821
    • Murphy SM, Davidson GL, Laura M, Salih M, Muntoni F, Lunn M, Blake J, Brandner S, Polke J, Davies M, Houlden H, Reilly MM (2011). Genetic mutation frequency in patients with hereditary sensory and autonomic neuropathies (HSAN).
    • Cleary JO, Wiseman FK, Norris FC, Price AN, Choy M, Tybulewicz VL, Ordidge RJ, Brandner S, Fisher EM, Lythgoe MF (2011). Structural correlates of active-staining following magnetic resonance microscopy in the mouse brain.. Neuroimage, 56(3), 974 - 983. doi:10.1016/j.neuroimage.2011.01.082
    • Saifee TA, Reilly MM, Ako E, Rugg-Gunn F, Brandner S, Lunn MP, Leary SM (2011). Sarcoidosis presenting as acute inflammatory demyelinating polyradiculoneuropathy.. Muscle Nerve, 43(2), 296 - 298. doi:10.1002/mus.21890
    • Galavotti S, Shaked-Rabi M, Tulchinsky E, Brandner S, Jones C, Salomoni P (2011). THE METABOLIC AUTOPHAGY PATHWAY REGULATES MIGRATION AND INVASION IN GLIOMA.
    • Thom M, An S, Martinian L, Sisodiya SM, Dean A, McEvoy A, Brandner S, Toma A (2011). 101 DNTs: histological subtypes, molecular genetics and clinical correlations in an adult epilepsy series.
    • Revesz T, Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD (2011). Brain biopsy in dementia: clinical indications and neuropathological diagnostic approach.
    • Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S (2011). Prion protein-induced tau phosphorylation: insight into a universal mechanism triggered by cerebral amyloid.
    • Akhtar S, Wenborn A, Brandner S, Collinge J, Lloyd SE (2011). Sex effects in mouse prion disease incubation time.. PLoS One, 6(12), e28741 - . doi:10.1371/journal.pone.0028741
    • Russo M, Laurá M, Polke JM, Davis MB, Blake J, Brandner S, Hughes RAC, Houlden H, Bennett DLH, Lunn MPT, Reilly MM (2011). Variable phenotypes are associated with PMP22 missense mutations. Neuromuscular Disorders, 21(2), 106 - 114.
    • Edgeworth JA, Sicilia A, Linehan J, Brandner S, Jackson GS, Collinge J (2011). A standardized comparison of commercially available prion decontamination reagents using the Standard Steel-Binding Assay.. J Gen Virol, 92(Pt 3), 718 - 726. doi:10.1099/vir.0.027201-0
    • Brandner S (2011). Diversity of prion diseases: (no) strains attached?. Acta Neuropathol, 121(1), 1 - 4. doi:10.1007/s00401-010-0775-x
    • Robinson JP, Vanbrocklin MW, Lastwika KJ, McKinney AJ, Brandner S, Holmen SL (2011). Activated MEK cooperates with Ink4a/Arf loss or Akt activation to induce gliomas in vivo.. Oncogene, 30(11), 1341 - 1350. doi:10.1038/onc.2010.513
    • Reiniger L, Lukic A, Linehan J, Rudge P, Collinge J, Mead S, Brandner S (2011). Tau, prions and Aβ: the triad of neurodegeneration.. Acta Neuropathol, 121(1), 5 - 20. doi:10.1007/s00401-010-0691-0
    • Hutton EJ, Carty L, Laurá M, Houlden H, Lunn MP, Brandner S, Mirsky R, Jessen K, Reilly MM (2011). c-Jun expression in human neuropathies: a pilot study.. J Peripher Nerv Syst, 16(4), 295 - 303. doi:10.1111/j.1529-8027.2011.00360.x

    2010

    • Saifee TA, Elliott KJ, Rabin N, Yong KL, D'Sa S, Brandner S, Lunn MP, Blake J, Reilly MM (2010). Bortezomib-induced inflammatory neuropathy.. J Peripher Nerv Syst, 15(4), 366 - 368. doi:10.1111/j.1529-8027.2010.00287.x
    • Kessler TM, Khan S, Panicker JN, Elneil S, Brandner S, Fowler CJ, Roosen A (2010). In the human urothelium and suburothelium, intradetrusor botulinum neurotoxin type A does not induce apoptosis: preliminary results.. Eur Urol, 57(5), 879 - 883. doi:10.1016/j.eururo.2009.09.023
    • Schmierer K, Thavarajah JR, An SF, Brandner S, Miller DH, Tozer DJ (2010). Effects of formalin fixation on magnetic resonance indices in multiple sclerosis cortical gray matter.. J Magn Reson Imaging, 32(5), 1054 - 1060. doi:10.1002/jmri.22381
    • Carswell C, Khalili-Shirazi A, Brandner S, Martins S, Drynda R, Collinge J, Mead S, Clarke A (2010). PAW35 Anti-prion protein monoclonal antibodies at low doses effectively treat prion disease in mice without side-effects.. J Neurol Neurosurg Psychiatry, 81(11), e33 - . doi:10.1136/jnnp.2010.226340.63
    • Lukic A, Wadsworth J, Brandner S, Rudge P, Hyare H, Collinge J, Reiniger L, Mead S, Gilmore C, Humberstone M (2010). POD01 Misleading MRI in two recent patients with variant Creutzfeldt-Jakob disease emphasises the importance of tissue diagnosis.. J Neurol Neurosurg Psychiatry, 81(11), e42 - . doi:10.1136/jnnp.2010.226340.101
    • Murphy S, Brandner S, Polke J, Manji H, Houlden H, Reilly MM (2010). POG11 A novel mutation in the nerve-specific 5'-UTR of the Cx32 gene causing CMTX1.. J Neurol Neurosurg Psychiatry, 81(11), e50 - . doi:10.1136/jnnp.2010.226340.133
    • Hoeck JD, Jandke A, Blake SM, Nye E, Spencer-Dene B, Brandner S, Behrens A (2010). Fbw7 controls neural stem cell differentiation and progenitor apoptosis via Notch and c-Jun.. Nat Neurosci, 13(11), 1365 - 1372. doi:10.1038/nn.2644
    • de Marco MF, Linehan J, Gill ON, Clewley JP, Brandner S (2010). Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain.. J Pathol, 222(4), 380 - 387. doi:10.1002/path.2767
    • Sandberg MK, Al-Doujaily H, Sigurdson CJ, Glatzel M, O'Malley C, Powell C, Asante EA, Linehan JM, Brandner S, Wadsworth JDF, Collinge J (2010). Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein. J GEN VIROL, 91, 2651 - 2657. doi:10.1099/vir.0024380-0
    • Siddique D, Hyare H, Wroe S, Webb T, Macfarlane R, Rudge P, Collinge J, Powell C, Brandner S, So PW, Walker S, Mead S, Yousry T, Thornton JS (2010). Magnetization transfer ratio may be a surrogate of spongiform change in human prion diseases.. Brain, 133(10), 3058 - 3068. doi:10.1093/brain/awq243
    • Revesz T, Schott JM, Holton JL, Reiniger L, Brandner S, Thom M, Warren JD (2010). Brain biopsy in dementia - clinical indications and diagnostic approach.
    • Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD, Revesz T (2010). Brain biopsy in dementia: clinical indications and diagnostic approach.. Acta Neuropathol, 120(3), 327 - 341. doi:10.1007/s00401-010-0721-y
    • Sommer CL, Brandner S, Dyck PJ, Harati Y, LaCroix C, Lammens M, Magy L, Mellgren SI, Morbin M, Navarro C, Powell HC, Schenone AE, Tan E, Urtizberea A, Weis J, Peripheral Nerve Society (2010). Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies.. J Peripher Nerv Syst, 15(3), 164 - 175. doi:10.1111/j.1529-8027.2010.00276.x
    • Wiseman FK, Sheppard O, Linehan JM, Brandner S, Tybulewicz VL, Fisher EM (2010). Generation of a panel of antibodies against proteins encoded on human chromosome 21.. J Negat Results Biomed, 9, 7 - . doi:10.1186/1477-5751-9-7
    • Brandner S (2010). Nanog, Gli, and p53: a new network of stemness in development and cancer.. EMBO J, 29(15), 2475 - 2476. doi:10.1038/emboj.2010.162
    • Lukic A, Beck J, Joiner S, Fearnley J, Sturman S, Brandner S, Wadsworth JD, Collinge J, Mead S (2010). Heterozygosity at polymorphic codon 219 in variant creutzfeldt-jakob disease.. Arch Neurol, 67(8), 1021 - 1023. doi:10.1001/archneurol.2010.184
    • Paisán-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, Houlden H (2010). Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations.. Mov Disord, 25(12), 1791 - 1800. doi:10.1002/mds.23221
    • Edgeworth JA, Gros N, Alden J, Joiner S, Wadsworth JD, Linehan J, Brandner S, Jackson GS, Weissmann C, Collinge J (2010). Spontaneous generation of mammalian prions.. Proc Natl Acad Sci U S A, 107(32), 14402 - 14406. doi:10.1073/pnas.1004036107
    • Sandberg MK, Al-Doujaily H, Sigurdson CJ, Glatzel M, O'Malley C, Powell C, Asante EA, Linehan JM, Brandner S, Wadsworth JD, Collinge J (2010). Chronic wasting disease prions are not transmissible to transgenic mice overexpressing human prion protein.. J Gen Virol, 91(Pt 10), 2651 - 2657. doi:10.1099/vir.0.024380-0
    • Asante EA, Linehan JM, Smidak M, Brandner S, Collinge J (2010). Inherited Prion Disease A117V is Transmissible to Transgenic Mice Expressing PRNP 117-valine. PRION, 4(3), 156 - 156.
    • Edgeworth JA, Gros N, Alden J, Joiner S, Wadsworth J, Linehan J, Brandner S, Jackson G, Weissmann C, Collinge J (2010). Spontaneous Formation of Prions in Brain Tissue. PRION, 4(3), 140 - 140.
    • Russo M, Laura M, Polke J, Davis MB, Blake J, Bradner S, Hughes RA, Houlden H, Lunn MP, Reilly M (2010). Variable phenotypes are associated with pmp22 missense mutations.
    • Murphy SM, Polke JM, Manji H, Brandner S, Houlden H, Reilly MM (2010). A novel mutation in the nerve-specific 5 ' UTR of the Cx32 gene causing CMTX1.
    • Hutton EJ, Carty L, Laura M, Houlden H, Lunn MP, Brandner S, Mirsky R, Jessen K, Reilly MM (2010). C-Jun expression in human neuropathies: a pilot study.
    • Urwin H, Authier A, Nielsen JE, Metcalf D, Powell C, Froud K, Malcolm DS, Holm I, Johannsen P, Brown J, Fisher EM, van der Zee J, Bruyland M, FReJA Consortium , Van Broeckhoven C, Collinge J, Brandner S, Futter C, Isaacs AM (2010). Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations.. Hum Mol Genet, 19(11), 2228 - 2238. doi:10.1093/hmg/ddq100
    • Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, Yousry TA, Miller DH (2010). High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.. Brain, 133(Pt 3), 858 - 867. doi:10.1093/brain/awp335
    • Robinson JP, VanBrocklin MW, Guilbeault AR, Signorelli DL, Brandner S, Holmen SL (2010). Activated BRAF induces gliomas in mice when combined with Ink4a/Arf loss or Akt activation.. Oncogene, 29(3), 335 - 344. doi:10.1038/onc.2009.333
    • Jacques TS, Swales A, Brzozowski MJ, Henriquez NV, Linehan JM, Mirzadeh Z, O' Malley C, Naumann H, Alvarez-Buylla A, Brandner S (2010). Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.. EMBO J, 29(1), 222 - 235. doi:10.1038/emboj.2009.327
    • Henriquez NV, Swales A, Jacques TS, Brandner S (2010). Gene expression profiling of brain tumours in a mouse model: insights into tumour-type specific transcripteome networks.
    • Wadsworth JD, Dalmau-Mena I, Joiner S, Linehan JM, O'Malley C, Powell C, Brandner S, Asante EA, Ironside JW, Hilton DA, Collinge J (2010). Effect of fixation on brain and lymphoreticular vCJD prions and bioassay of key positive specimens from a retrospective vCJD prevalence study.. J Pathol, , - . doi:10.1002/path.2821

    2009

    • Lukic A, Beck JA, Wadsworth JDF, Brandner S, Collinge J, Mead S (2009). HETEROZYGOSITY AT POLYMORPHIC CODON 219 IN TWO VARIANT CREUTZFELDT-JAKOB DISEASE PATIENTS. doi:10.1136/jnnp.2009.191759o
    • Kaski D, Pennington C, Beck J, Poulter M, Uphill J, Bishop M, Lineham J, Powell C, Brandner S, Knight R, Collinge J, Mead S (2009). INHERITED PRION DISEASE WITH 4-OCTAPEPTIDE REPEAT INSERTION - A DISEASE THAT REQUIRES THE INTERACTION OF MULTIPLE GENETIC RISK FACTORS. doi:10.1136/jnnp.2009.191759p
    • Parkes H, So PW, Brandner S, An S, Miller D, Yousry T, Schmierer K (2009). Quantifying cortical pathology in multiple sclerosis using high-field MRI.
    • Webb T, Mead S, Beck J, Uphill J, Pal S, Hampson S, Wadsworth JD, Dalmau Mena I, O'Malley C, Wroe S, Schapira A, Brandner S, Collinge J (2009). Seven year discordance in age at onset in monozygotic twins with inherited prion disease (P102L). Neuropathology and Applied Neurobiology, 35(4), 427 - 432. doi:10.1111/j.1365-2990.2009.01012.x
    • Achilli F, Bros-Facer V, Williams HP, Banks GT, AlQatari M, Chia R, Tucci V, Groves M, Nickols CD, Seburn KL, Kendall R, Cader MZ, Talbot K, van Minnen J, Burgess RW, Brandner S, Martin JE, Koltzenburg M, Greensmith L, Nolan PM, Fisher EMC (2009). An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy.. Disease Models and Mechanisms, 2(7-8), 359 - 373. doi:10.1242/dmm.002527
    • Roosen A, Datta SN, Chowdhury RA, Patel PM, Kalsi V, Elneil S, Dasgupta P, Kessler TM, Khan S, Panicker J, Fry CH, Brandner S, Fowler CJ, Apostolidis A (2009). Suburothelial myofibroblasts in the human overactive bladder and the effect of botulinum neurotoxin type A treatment. European Urology, 55(6), 1440 - 1449. doi:10.1016/j.eururo.2008.11.009
    • Rees J, Brandner S, Howard R, Jager R, Short S, Thomas DT, E Z, G (2009). Neuro-oncology. In Clarke C, Howard R, Rossor M, Shorvon S (Ed.), Neurology: A Queen Square textbook (pp. 771 - 822). : Wiley-Blackwell.
    • An S, Henriquez N, Puls F, Brandner S (2009). Oligodendrogliomas: relation of morphology to 1p/19q genotype.
    • Laura M, Lunn M, Gow D, Roberts M, Carlstedt T, Yousry T, John P, Brandner S, Reilly MM (2009). PERINEURIOMA OF SCIATIC NERVE: REPORT OF TWO CASES.
    • Henriquez N, Jacques TS, Swales A, Brandner S (2009). Stem cells, progenitor cells and brain tumours: how related are they?.
    • Roosen A, Apostolidis A, Elneil S, Khan S, Panicker J, Brandner S, Fowler CJ, Kessler TM (2009). Cadherin-11 up-regulation in overactive bladder suburothelial myofibroblasts. The Journal of Urology, 182(1), 190 - 195. doi:10.1016/j.juro.2009.02.148
    • Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Osiguwa O, Tomlinson A, Joiner S, Brandner S, Wadsworth JD, Collinge J (2009). Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. Journal of General Virology, 90(3), 546 - 558. doi:10.1099/vir.0.007930-0

    2008

    • Collinge J, Whitfield J, McKintosh E, Frosh A, Mead S, Hill AF, Brandner S, Thomas D, Alpers MP (2008). A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1510), 3725 - 3739. doi:10.1098/rstb.2008.0068
    • Brandner S, Whitfield J, Boone K, Puwa A, O'Malley C, Linehan JM, Joiner S, Scaravilli F, Calder I, Alpers MP, Wadsworth JD, Collinge J (2008). Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1510), 3755 - 3763. doi:10.1098/rstb.2008.0091
    • Wadsworth JDF, Joiner S, Linehan JM, Asante EA, Brandner S, Collinge J (2008). Review: The origin of the prion agent of kuru: molecular and biological strain typing. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1510), 3747 - 3753. doi:10.1098/rstb.2008.0069
    • Webb TEF, Poulter M, Beck J, Uphill J, Adamson G, Campbell T, Linehan J, Powell C, Brandner S, Pal S, Siddique D, Wadsworth JD, Joiner S, Alner K, Petersen C, Hampson S, Rhymes C, Treacy C, Storey E, Geschwind MD, Nemeth AH, Wroe S, Collinge J, Mead S (2008). Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain, 131(10), 2632 - 2646. doi:10.1093/brain/awn202
    • Webb TEF, Pal S, Siddique D, Heaney DC, Linehan JM, Wadsworth JDF, Joiner S, Beck J, Wroe SJ, Stevenson V, Brandner S, Mead S, Collinge J (2008). First report of Creutzfeldt-Jakob disease occurring in 2 siblings unexplained by PRNP mutation. Journal of Neuropathology and Experimental Neurology, 67(9), 838 - 841. doi:10.1097/NEN.0b013e318182f36e
    • O'Shea M, Maytham EG, Linehan JM, Brandner S, Collinge J, Lloyd SE (2008). Investigation of Mcp1 as a quantitative trait gene for prion disease incubation time in mouse. Genetics, 180(1), 559 - 566. doi:10.1534/genetics.108.090984
    • O'Shea M, Maytham EG, Linehan JM, Brandner S, Collinge J, Lloyd SE (2008). Investigation of mcp1 as a quantitative trait gene for prion disease incubation time in mouse.. Genetics, 180(1), 559 - 566. doi:10.1534/genetics.108.090894
    • Schmierer K, Parkes H, So PW, An SF, Brandner S, Miller DH, Yousry TA (2008). Magnetization transfer ratio: a predictor of neuronal loss in multiple sclerosis cortical gray matter?.
    • Isaacs AM, Powell C, Webb TE, Linehan JM, Collinge J, Brandner S (2008). Lack of TAR-DNA binding protein-43 (TDP-43) pathology in human prion diseases. Neuropathology and Applied Neurobiology, 34(4), 446 - 456. doi:10.1111/j.1365-2990.2008.00963.x
    • White MD, Farmer M, Mirabile I, Brandner S, Collinge J, Mallucci GR (2008). Single treatment with RNAi against prion protein rescues early neuronal dysfunction and prolongs survival in mice with prion disease. Proceedings of the National Academy of Sciences of the United States of America, 105(29), 10238 - 10243. doi:10.1073/pnas.0802759105
    • Wadsworth JDF, Joiner S, Linehan JM, Desbruslais M, Fox K, Cooper S, Cronier S, Asante EA, Mead S, Brandner S, Hill AF, Collinge J (2008). Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.. Proceedings of the National Academy of Sciences of the United States of America, 105(10), 3885 - 3890. doi:10.1073/pnas.0800190105
    • Sommer C, Brandner S, Dyck PJ, Magy L, Mellgren SI, Morbin M, Schenone A, Tan E, Weis J, ENMC (2008). 147th ENMC international workshop: guideline on processing and evaluation of sural nerve biopsies, 15-17 December 2006, Naarden, The Netherlands.. Neuromuscul Disord, 18(1), 90 - 96. doi:10.1016/j.nmd.2007.08.010
    • Wadsworth JDF, Powell C, Beck JA, Joiner S, Linehan JM, Brandner S, Mead S, Collinge J (2008). Molecular diagnosis of human prion disease. Methods in Molecular Biology, 459, 197 - 227. doi:10.1007/978-1-59745-234-2_14
    • Swales A, Naumann H, Cuadrado P, Jacques T, Brandner S (2008). Neural stem cells differentially govern tumorigenesis within the brain dependent on their early genetic profile.
    • Cuadrado PMR, Naumann H, Jacques TS, Brandner S (2008). Wnt signalling in neural stem cell differentiation and tumorigenesis in the CNS.

    2007

    • Nateri AS, Raivich G, Gebhardt C, Da Costa C, Naumann H, Vreugdenhil M, Makwana M, Brandner S, Adams RH, Jefferys JG, Kann O, Behrens A (2007). ERK activation causes epilepsy by stimulating NMDA receptor activity.. EMBO J, 26(23), 4891 - 4901. doi:10.1038/sj.emboj.7601911
    • Scheithauer BW, Brandner S, Soffer D (2007). Spinal paraganglioma. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Ed.), WHO classification of tumours of the central nervous system (pp. 117 - 119). : International Agency for Research on Cancer.
    • Wadsworth JDF, Joiner S, Fox K, Linehan JM, Desbruslais M, Brandner S, Asante EA, Collinge J (2007). Prion infectivity in variant Creutzfeldt-Jakob disease rectum. Gut, 56(1), 90 - 94. doi:10.1136/gut.2006.091637
    • Paulus W, Brandner S (2007). Choroid plexus tumours. In Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (Ed.), WHO classification of tumours of the central nervous system (pp. 82 - 85). : International Agency for Research on Cancer.
    • Mallucci GR, White MD, Farmer M, Dickinson A, Khatun H, Powell AD, Brandner S, Jefferys JG, Collinge J (2007). Targeting cellular prion protein reverses early cognitive deficits and neurophysiological dysfunction in prion-infected mice. Neuron, 53(3), 325 - 335. doi:10.1016/j.neuron.2007.01.005
    • Webb T, Pal S, Siddique D, Heaney D, Brandner S, Wroe S, Stevenson V, Collinge J (2007). Sporadic Creutzfeldt-Jakob disease occurring in two siblings.
    • Nayeem N, Kerr F, Naumann H, Linehan J, Lovestone S, Brandner S (2007). Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella. MOL CELL NEUROSCI, 34(3), 400 - 408. doi:10.1016/j.mcn.2006.11.014
    • Nayeem N, Kerr F, Naumann H, Linehan J, Lovestone S, Brandner S (2007). Hyperphosphorylation of tau and neurofilaments and activation of CDK5 and ERK1/2 in PTEN-deficient cerebella. Molecular and Cellular Neuroscience, 34(3), 400 - 408. doi:10.1016/j.mcn.2006.11.014
    • An S, Brandner S (2007). Clinical and diagnostic use of-1p/-19q genotype in oligodendroglial tumours: correlation on histological features - a study on 105 patients.
    • Mensah A, Mulligan C, Linehan J, Ruf S, O'Doherty A, Grygalewicz B, Shipley J, Groet J, Tybulewicz V, Fisher EMC, Brandner S, Nizetic D (2007). An additional human chromosome 21 causes suppression of neural fate of pluripotent mouse embryonic stem cells in a teratoma model.. BMC Dev Biol, 7, 131 - . doi:10.1186/1471-213X-7-131
    • Nateri AS, Raivich G, Gebhardt C, Da Costa C, Naumann H, Vreugdenhil M, Makwana M, Brandner S, Adams RH, Jefferys JGR, Kann O, Behrens A (2007). ERK activation causes epilepsy by stimulating NMDA receptor activity. The EMBO Journal, 26(23), 4891 - 4901. doi:10.1038/sj.emboj.7601911
    • Parkes HG, So PW, Miller DH, Brandner S, Yousry TA, Schmierer K (2007). High field (9.4T) magnetic resonance reveals cortical lesions in multiple sclerosis brain.
    • Webb T, Mead S, Poulter M, Beck J, Uphill J, Campbell T, Adamson G, Pal S, Siddique D, Treacy C, Brandner S, Wroe S, Collinge J (2007). Inherited prion disease with the P102L mutation: Update of a worldwide kindred originating in England and multiple unrelated European kindreds.
    • Sommer C, Brandner S, Dyck PJ, Lacroix C, Lammens M, Magy L, Mellgren SI, Morbin M, Navarro C, Powell HC, Schenone A, Tan E, Weis J, Harati Y (2007). Development of a guideline on processing and evaluation of nerve biopsies.

    2006

    • Wroe SJ, Pal S, Siddique D, Hyare H, MacFarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JDF, Hewitt P, Collinge J (2006). Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. The Lancet, 368(9552), 2061 - 2067.
    • Brooks S, Daley F, Johns P, Brandner S, Short SC (2006). Pescadillo and CYP1B1: Novel metabolic targets in glioma.
    • Nayeem N, Kerr F, Naumann H, Lovestone S, Brandner S (2006). Hyperphosphorylation of tau and neurofilament by constitutive activation of CDK5 in PTEN deficient cerebellum.
    • Kerr F, Rickle A, Nayeem N, Brandner S, Cowburn RF, Lovestone S (2006). PTEN, a negative regulator of P13 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3. FEBS Letters, 580(13), 3121 - 3128.
    • Webb T, Pal S, Siddique D, Brandner S, Wroe S, Collinge J (2006). Bilateral sequential alien limb in a pathologically confirmed case of Creutzfeldt-Jakob disease (SCJD).
    • Wadsworth JDF, Joiner S, Linehan JM, Cooper S, Powell C, Mallinson G, Buckell J, Gowland I, Asante EA, Budka H, Brandner S, Collinge J (2006). Phenotypic heterogeneity in inherited prion disease (P102L) is associated with differential propagation of protease-resistant wild-type and mutant prion protein. Brain, 129(6), 1557 - 1569.
    • Asante EA, Linehan JM, Gowland I, Joiner S, Fox K, Cooper S, Osiguwa O, Gorry M, Welch J, Houghton R, Desbruslais M, Brandner S, Wadsworth JD, Collinge J (2006). Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proceedings of the National Academy of Sciences of the United States of America, 103(28), 10759 - 10764. doi:10.1073/pnas.0604292103
    • Jacques TS, Naumann H, Brandner S (2006). A novel role for the tumour suppressor gene, PTEN, in the development of tumours from neural stem cells.
    • Kerr F, Rickle A, Nayeem N, Brandner S, Cowburn RF, Lovestone S (2006). PTEN, a negative regulator of PI3 kinase signalling, alters tau phosphorylation in cells by mechanisms independent of GSK-3.. FEBS Lett, 580(13), 3121 - 3128. doi:10.1016/j.febslet.2006.04.064

    2005

    • Korenkov AI, Imhof HG, Brandner S, Taub E, Huguenin PU, Gaab MR, Yonekawa Y (2005). Growth retardation and bilateral cataracts followed by anaplastic meningioma 23 years after high-dose cranial and whole-body irradiation for acute lymphoblastic leukemia: case report and review of the literature.. J Neurooncol, 74(2), 195 - 199. doi:10.1007/s11060-004-6151-8
    • Jacques TS, Ikenberg K, Reynolds S, Naumann H, Brandner S (2005). A novel model of tumour formation by neural stem cells.
    • McKintosh E, Jackson G, Flechsig E, Prodromidou K, Hirsch P, Linehan J, Brandner S, Clarke A, Weissmann C, Collinge J (2005). A detergent-enzyme method for effective prion decontamination of surgical steel.
    • Jackson GS, McKintosh E, Flechsig E, Prodromidou K, Hirsch P, Linehan J, Brandner S, Clarke AR, Weissmann C, Collinge J (2005). An enzyme-detergent method for effective prion decontamination of surgical steel. Journal of General Virology, 86(3), 869 - 878.
    • Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sorensen SA, Gydesen S, EMC F, Collinge J (2005). Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. NAT GENET, 37(8), 806 - 808. doi:10.1038/ng1609
    • Kristiansen M, Messenger MJ, Klohn PC, Brandner S, Wadsworth JD, Collinge J, Tabrizi SJ (2005). Disease-related prion protein forms aggresomes in neuronal cells leading to caspase-activation and apoptosis. Journal of Biological Chemistry, 280(46), 38851 - 38861. doi:10.1074/jbc.M506600200
    • O'Doherty A, Ruf S, Mulligan C, Hildreth V, Errington ML, Cooke S, Sesay A, Modino S, Vanes L, Hernandez D, Linehan JM, Sharpe PT, Brandner S, Bliss TV, Henderson DJ, Nizetic D, Tybulewicz VL, Fisher EM (2005). An aneuploid mouse strain carrying human chromosome 21 with Down Syndrome phenotypes. Science, 309(5743), 2033 - 2037. doi:10.1126/science.1114535
    • Joiner S, Linehan JM, Brandner S, Wadsworth JDF, Collinge J (2005). High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease. Gut, 54(10), 1506 - 1508.
    • Siddique D, Kennedy A, Thomas D, Wroe S, Stevens J, Wadsworth J, Brandner S, Linehan J, Joiner S, Jones J, Frosh A, Hill D, Tolley N, Rossor M, Collinge J (2005). Tonsil biopsy in the investigation of suspected variant Creutzfeldt-.Jakob disease - A cohort study of 50 patients.

    2004

    • Wadsworth JD, Asante EA, Desbruslais M, Linehan JM, Joiner S, Gowland I, Welch J, Stone L, Lloyd SE, Hill AF, Brandner S, Collinge J (2004). Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science, 306(5702), 1793 - 1796. doi:10.1126/science.1103932
    • Anderson L, Rossi D, Linehan J, Brandner S, Weissmann C (2004). Transgene-driven expression of the Doppel protein in Purkinje cells causes Purkinje cell degeneration and motor impairment. Proceedings of the National Academy of Sciences of the United States of America, 101(10), 3644 - 3649. doi:10.1073/pnas.0308681101
    • Baumann F, Bjeljac M, Kollias SS, Baumert BG, Brandner S, Rousson V, Yonekawa Y, Bernays RL (2004). Combined thalidomide and temozolomide treatment in patients with glioblastoma multiforme.. J Neurooncol, 67(1-2), 191 - 200.
    • Himmelmann B, Brandner S, Jung HH, Schoedon G, Schuknecht B, Schaffner A (2004). Severe hypothermia in a patient with cerebral relapse of Whipple's disease.. Infection, 32(2), 119 - 121. doi:10.1007/s15010-004-3024-1
    • Lloyd SE, Thompson SR, Beck JA, Linehan JM, Wadsworth JD, Brandner S, Collinge J, Fisher EMC (2004). Identification and characterization of a novel mouse prion gene allele.. Mamm Genome, 15(5), 383 - 389. doi:10.1007/s00335-004-3041-5
    • Eckhardt BP, Brandner S, Zollikofer CL, Wentz KU (2004). Primary cerebral leiomyosarcoma in a child. Pediatric Radiology, 34(6), 495 - 498.
    • Horstmann S, Perry A, Reifenberger G, Giangaspero F, Huang H, Hara A, Masuoka J, Rainov NG, Bergmann M, Heppner FL, Brandner S, Chimelli L, Montagna N, Jackson T, Davis DG, Markesbery WR, Ellison DW, Weller RO, Taddei GL, Conti R, Del Bigio MR, Gonzalez-Campora R, Radhakrishnan VV, Soylemezoglu F, Uro-Coste E, Qian J, Kleihues P, Ohgaki H (2004). Genetic and expression profiles of cerebellar liponeurocytomas. Brain Pathology, 14(3), 281 - 289.
    • Lloyd SE, Linehan JM, Desbruslais M, Joiner S, Buckell J, Brandner S, Wadsworth JD, Collinge J (2004). Characterization of two distinct prion strains derived from bovine spongiform encephalopathy transmissions to inbred mice. Journal of General Virology, 85(8), 2471 - 2478.
    • Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JDF, Collinge J (2004). Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. The Lancet, 364(9441), 1260 - 1262.
    • Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P, Abuin A, Grau E, Geppert M, Livi GP, Creasy CL, Martin A, Hargreaves I, Heales SJ, Okada H, Brandner S, Schulz JB, Mak T, Downward J (2004). Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice.. Mol Cell Biol, 24(22), 9848 - 9862. doi:10.1128/MCB.24.22.9848-9862.2004
    • Martins LM, Morrison A, Klupsch K, Fedele V, Moisoi N, Teismann P, Abuin A, Grau E, Geppert M, Livi GP, Creasy CL, Martin A, Hargreaves I, Heales SJ, Okada H, Brandner S, Schulz JB, Mak T, Downward J (2004). Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Molecular and Cellular Biology, 24(22), 9848 - 9862.
    • Hafezparast M, Brandner S, Linehan J, Martin JE, Collinge J, Fisher EMC (2004). Prion disease incubation time is not affected in mice heterozygous for a dynein mutation. Biochemical and Biophysical Research Communications, 326(1), 18 - 22.

    2003

    • Brandner S (2003). CNS pathogenesis of prion diseases. British Medical Bulletin, 66(1), 131 - 139.
    • Mallucci G, Dickinson A, Linehan J, Klohn PC, Brandner S, Collinge J (2003). Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science, 302(5646), 871 - 874. doi:10.1126/science.1090187
    • Marino S, Hoogervoorst D, Brandner S, Berns A (2003). Rb and p107 are required for normal cerebellar development and granule cell survival but not for Purkinje cell persistence. Development, 130(15), 3359 - 3368. doi:10.1242/dev.00553
    • Wiesli P, Brändle M, Brandner S, Kollias SS, Bernays RL (2003). Extensive spherical amyloid deposition presenting as a pituitary tumor.. J Endocrinol Invest, 26(6), 552 - 555.
    • Capone Mori A, Hoeltzenbein M, Poetsch M, Schneider JF, Brandner S, Boltshauser E (2003). Lhermitte-Duclos disease in 3 children: a clinical long-term observation.. Neuropediatrics, 34(1), 30 - 35. doi:10.1055/s-2003-38623
    • Collinge J, Brandner S, Kennedy A, Rossor M, Smith P, Stevens J, Rudge P (2003). A 38-year-old man with a 9 month history of neurological and cognitive impairment. The Lancet Neurology, 2(3), 189 - 194.
    • Haegele L, Ingold B, Naumann H, Tabatabai G, Ledermann B, Brandner S (2003). Wnt signalling inhibits neural differentiation of embryonic stem cells by controlling bone morphogenetic protein expression. Molecular and Cellular Neuroscience, 24(3), 696 - 708.
    • White AR, Enever P, Tayebi M, Mushens R, Linehan J, Brandner S, Anstee D, Collinge J, Hawke S (2003). Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature, 422(6927), 80 - 83. doi:10.1038/nature01457

    2002

    • Glatzel M, Brandner S, Klein MA, Horstmann S, Aguzzi A (2002). Prions - role of the peripheral nervous system. Virus Research, 82(1-2), 53 - 53.
    • Joiner S, Linehan J, Brandner S, Wadsworth JD, Collinge J (2002). Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 73(5), 597 - 598.
    • Bernays RL, Kollias SS, Khan N, Brandner S, Meier S, Yonekawa Y (2002). Histological yield, complications, and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. Journal of Neurosurgery, 97(2), 354 - 362.
    • Jung HH, Brandner S (2002). Malignant McLeod myopathy. Muscle and Nerve, 26(3), 424 - 427.
    • Boison D, Scheurer L, Zumsteg V, Rulicke T, Litynski P, Fowler B, Brandner S, Mohler H (2002). Neonatal hepatic steatosis by disruption of the adenosine kinase gene. Proceedings of the National Academy of Sciences of the United States of America, 99(10), 6985 - 6990.
    • Marino S, Krimpenfort P, Leung C, van der Korput HA, Trapman J, Camenisch I, Berns A, Brandner S (2002). PTEN is essential for cell migration but not for fate determination and tumourigenesis in the cerebellum. Development, 129(14), 3513 - 3522.

    2001

    • Brandner S, Krimpenfort P, Berns A, Marino S (2001). The role of PTEN in cerebellar development and differentiation. ACTA NEUROPATHOL, 102(5), 520 - 520.
    • Masuoka J, Brandner S, Paulus W, Soffer D, Vital A, Chimelli L, Jouvet A, Yonekawa Y, Kleihues P, Ohgaki H (2001). Germline SDHD mutation in paraganglioma of the spinal cord.. Oncogene, 20(36), 5084 - 5086. doi:10.1038/sj.onc.1204579
    • Jung HH, Russo D, Redman C, Brandner S (2001). Kell and XK immunohistochemistry in McLeod myopathy.. Muscle Nerve, 24(10), 1346 - 1351.
    • Alkadhi H, Keller M, Brandner S, Yonekawa Y, Kollias SS (2001). Neuroimaging of cerebellar liponeurocytoma. Case report.. J Neurosurg, 95(2), 324 - 331. doi:10.3171/jns.2001.95.2.0324
    • Behrens A, Brandner S, Genoud N, Aguzzi A (2001). Normal neurogenesis and scrapie pathogenesis in neural grafts lacking the prion protein homologue Doppel.. EMBO Rep, 2(4), 347 - 352. doi:10.1093/embo-reports/kve088
    • Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, Brandner S, Daniels G, Buck A, Kollias S, Hess K (2001). McLeod syndrome: X-linked choreoacanthocytosis with predominant psychiatric manifestations. J NEUROL NEUROSUR PS, 70(2), 279 - 279.
    • Reis RM, Herva R, Brandner S, Koivukangas J, Mironov N, Bär W, Kleihues P, Ohgaki H (2001). Second primary glioblastoma.. J Neuropathol Exp Neurol, 60(2), 208 - 215.
    • Glatzel M, Brandner S, Klein MA, Aguzzi A (2001). Prions: from neurografts to neuroinvasion.. Methods Mol Med, 59, 129 - 147. doi:10.1385/1-59259-134-5:129
    • Aguzzi A, Brandner S, Fischer MB, Furukawa H, Glatzel M, Hawkins C, Heppner FL, Montrasio F, Navarro B, Parizek P, Pekarik V, Prinz M, Raeber AJ, Röckl C, Klein MA (2001). Spongiform encephalopathies: insights from transgenic models.. Adv Virus Res, 56, 313 - 352.

    2000

    • Brandner S, Klein MA, Frigg R, Pekarik V, Parizek P, Raeber A, Glatzel M, Schwarz P, Rülicke T, Weissmann C, Aguzzi A (2000). Neuroinvasion of prions: insights from mouse models.. Exp Physiol, 85(6), 705 - 712.
    • Brandner S, Marine S, Kielmann M, Hardegger R, Fodde R, Aguzzi A (2000). The role of the adenomatous polyposis coli (APC) protein in neural differentiation. BRAIN PATHOL, 10(4), 762 - 762.
    • Benninger Y, Marino S, Hardegger R, Weissmann C, Aguzzi A, Brandner S (2000). Differentiation and histological analysis of embryonic stem cell-derived neural transplants in mice.. Brain Pathol, 10(3), 330 - 341.
    • Krähenbühl S, Brandner S, Kleinle S, Liechti S, Straumann D (2000). Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure.. Liver, 20(4), 346 - 348.
    • Huisman TA, Brandner S, Niggli F, Betts DR, Boltshauser E, Martin E (2000). Malignant rhabdoid tumor of the brain: quantitative 1H MR-spectroscopy and cytogenetics.. Neuropediatrics, 31(3), 159 - 161. doi:10.1055/s-2000-7489
    • Zehnder P, Jenni W, Brandner S, Stäubli M, Waespe W, Aeschlimann A (2000). [Vasculitis and mononeuritis multiplex].. Praxis (Bern 1994), 89(18), 776 - 784.
    • Glatzel M, Klein MA, Brandner S, Aguzzi A (2000). Prions: from neurografts to neuroinvasion.
    • Aguzzi A, Raeber AJ, Brandner S, Frigg R, Raeber AJ, Hegyi I, Rockl C, Fischer MB, Pekarik V, Huber GF, Musahl C, Furukawa H, Glatzel M, Parizek P, Klein MA (2000). Molecular pathology of prion diseases. J PATHOL, 190, 65A - 65A.
    • Moosmann P, Brandner S, Kleinle S, Frauchiger B (2000). Hyperventilation due to mitochondrial myopathy.. J R Soc Med, 93(1), 25 - 26.
    • Huisman TA, Brandner S, Niggli F, Kacl G, Willi UV, Martin E (2000). Meningeal hemangiopericytoma in childhood.. Eur Radiol, 10(7), 1073 - 1075.
    • Glatzel M, Klein MA, Brandner S, Aguzzi A (2000). Prions: from neurografts to neuroinvasion.. Arch Virol Suppl, (16), 3 - 12.
    • Aguzzi A, Klein MA, Montrasio F, Pekarik V, Brandner S, Furukawa H, Käser P, Röckl C, Glatzel M (2000). Prions: pathogenesis and reverse genetics.. Ann N Y Acad Sci, 920, 140 - 157.
    • Brandner S, Klein MA, Aguzzi A (2000). [Mechanisms of neuroinvasion by prions: molecular principles and present state of research].. Schweiz Med Wochenschr, 130(12), 435 - 442.

    1999

    • Paulus W, Brandner S (1999). Synaptophysin in choroid plexus epithelial cells: no useful aid in differential diagnosis.. J Neuropathol Exp Neurol, 58(10), 1111 - 1112.
    • Aguzzi A, Brandner S (1999). Shrinking prions: new folds to old questions.. Nat Med, 5(5), 486 - 487. doi:10.1038/8366
    • Raeber AJ, Sailer A, Hegyi I, Klein MA, Rülicke T, Fischer M, Brandner S, Aguzzi A, Weissmann C (1999). Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication.. Proc Natl Acad Sci U S A, 96(7), 3987 - 3992.
    • Aguzzi A, Brandner S (1999). The genetics of prions--a contradiction in terms?. Lancet, 354 Suppl 1, SI22 - SI25.
    • Brandner S, Klein MA, Aguzzi A (1999). A crucial role for B cells in neuroinvasive scrapie.. Transfus Clin Biol, 6(1), 17 - 23. doi:10.1016/S1246-7820(99)80007-X
    • Lichtlen P, Georgiev O, Schaffner W, Aguzzi A, Brandner S (1999). The heavy metal-responsive transcription factor-1 (MTF-1) is not required for neural differentiation.. Biol Chem, 380(6), 711 - 715. doi:10.1515/BC.1999.089

    1998

    • Rovigatti U, Afanasyeva T, Brandner S, Hainfellner JA, Kiess M, Maddalena A, Malin G, Rülicke T, Steinbach J, Weissenberger J, Aguzzi A (1998). Transgenic mice as research tools in neurocarcinogenesis.. J Neurovirol, 4(2), 159 - 174.
    • Raeber AJ, Klein MA, Frigg R, Brandner S, Blättler T, Aguzzi A (1998). [Significance of prion protein in transmission of prions and in pathogenesis of spongiform encephalopathies].. Wien Med Wochenschr, 148(4), 74 - 77.
    • Brandner S, Isenmann S, Kühne G, Aguzzi A (1998). Identification of the end stage of scrapie using infected neural grafts.. Brain Pathol, 8(1), 19 - 27.
    • Aguzzi A, Klein MA, Blattler T, Raber AJ, Hegyi I, Frigg R, Brandner S (1998). Pathogenesis of prion diseases: A progress report.
    • Aguzzi A, Weissmann C, Blattler T, Raeber AJ, Brandner S, Klein MA (1998). Prions: Neurotoxicity and neuroinvasion. N-S ARCH PHARMACOL, 358(1), R11 - R11.
    • Aguzzi A, Brandner S (1998). Scrapie pathogenesis in brain grafts.
    • Aguzzi A, Klein MA, Musahl C, Raeber AJ, Blattler T, Hegyi I, Frigg R, Brandner S (1998). Use of brain grafts to study the pathogenesis of prion diseases. ESSAYS BIOCHEM, 33, 133 - 147.
    • Aguzzi A, Klein MA, Musahl C, Raeber AJ, Blättler T, Hegyi I, Frigg R, Brandner S (1998). Use of brain grafts to study the pathogenesis of prion diseases.. Essays Biochem, 33, 133 - 147.
    • Weissmann C, Fischer M, Raeber A, Büeler H, Sailer A, Shmerling D, Rülicke T, Brandner S, Aguzzi A (1998). The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.. Rev Sci Tech, 17(1), 278 - 290.
    • Shmerling D, Hegyi I, Fischer M, Blättler T, Brandner S, Götz J, Rülicke T, Flechsig E, Cozzio A, von Mering C, Hangartner C, Aguzzi A, Weissmann C (1998). Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions.. Cell, 93(2), 203 - 214.
    • Kleinle S, Schneider V, Moosmann P, Brandner S, Krähenbühl S, Liechti-Gallati S (1998). A novel mitochondrial tRNA(Phe) mutation inhibiting anticodon stem formation associated with a muscle disease.. Biochem Biophys Res Commun, 247(1), 112 - 115. doi:10.1006/bbrc.1998.8729
    • Raeber AJ, Brandner S, Klein MA, Benninger Y, Musahl C, Frigg R, Roeckl C, Fischer MB, Weissmann C, Aguzzi A (1998). Transgenic and knockout mice in research on prion diseases.. Brain Pathol, 8(4), 715 - 733.
    • Aguzzi A, D'Angelo MG, Klein MA, Frigg R, Fischer MB, Raeber AJ, Röckl C, Musahl C, Hegyi I, Brandner S (1998). [The new research frontier on prion disease].. Pathologica, 90(6), 743 - 752.
    • Weissmann C, Fischer M, Raeber A, Bueler HR, Sailer A, Shmerling D, Rulicke T, Brandner S, Aguzzi A (1998). The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.
    • Weissmann C, Fischer M, Raeber A, Bueler H, Shmerling D, Sailer A, Rulicke T, Brandner S, Aguzzi A (1998). The use of transgenic mice ln the investigation of transmissible spongiform encephalopathies.

    1997

    • Duffner F, Brandner S, Opitz H, Klier R, Grote EH (1997). Primary Candida albicans empyema associated with epidural hematomas in craniocervical junction.. Clin Neuropathol, 16(3), 143 - 146.
    • Aguzzi A, Bitiftler T, Klein M, Brandner S, Raeber A, Flechsig E, Weissmann C (1997). Neurotoxicity and neuroinvasiveness of prions.
    • Blättler T, Brandner S, Raeber AJ, Klein MA, Voigtländer T, Weissmann C, Aguzzi A (1997). PrP-expressing tissue required for transfer of scrapie infectivity from spleen to brain.. Nature, 389(6646), 69 - 73. doi:10.1038/37981
    • Aguzzi A, Maddalena A, Brandner S, Klein M (1997). [Molecular pathogenesis of spongiform encephalopathy].. Pathologica, 89(5), 481 - 490.
    • Raeber AJ, Race RE, Brandner S, Priola SA, Sailer A, Bessen RA, Mucke L, Manson J, Aguzzi A, Oldstone MB, Weissmann C, Chesebro B (1997). Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie.. EMBO J, 16(20), 6057 - 6065. doi:10.1093/emboj/16.20.6057
    • Aguzzi A, Blättler T, Klein MA, Räber AJ, Hegyi I, Frigg R, Brandner S, Weissmann C (1997). Tracking prions: the neurografting approach.. Cell Mol Life Sci, 53(6), 485 - 495.
    • Aguzzi A, Raeber A, Blättler T, Flechsig E, Klein M, Weissmann C, Brandner S (1997). Neurotoxicity and neuroinvasiveness of prions.. J Neurovirol, 3 Suppl 1, S23 - S24.

    1996

    • Isenmann S, Brandner S, Kühne G, Boner J, Aguzzi A (1996). Comparative in vivo and pathological analysis of the blood-brain barrier in mouse telencephalic transplants.. Neuropathol Appl Neurobiol, 22(2), 118 - 128.
    • Isenmann S, Brandner S, Aguzzi A (1996). Neuroectodermal grafting: a new tool for the study of neurodegenerative diseases.. Histol Histopathol, 11(4), 1063 - 1073.
    • Fischer M, Rülicke T, Raeber A, Sailer A, Moser M, Oesch B, Brandner S, Aguzzi A, Weissmann C (1996). Prion protein (PrP) with amino-proximal deletions restoring susceptibility of PrP knockout mice to scrapie.. EMBO J, 15(6), 1255 - 1264.
    • Aguzzi A, Brandner S, Marino S, Steinbach JP (1996). Transgenic and knockout mice in the study of neurodegenerative diseases.. J Mol Med (Berl), 74(3), 111 - 126.
    • Tschopp RR, Brandner S, Marino S, Bothe K, Horak I, Rethwilm A, Aguzzi A (1996). Analysis of the determinants of neurotropism and neurotoxicity of HFV in transgenic mice.. Virology, 216(2), 338 - 346. doi:10.1006/viro.1996.0069
    • Lindberg RL, Porcher C, Grandchamp B, Ledermann B, Bürki K, Brandner S, Aguzzi A, Meyer UA (1996). Porphobilinogen deaminase deficiency in mice causes a neuropathy resembling that of human hepatic porphyria.. Nat Genet, 12(2), 195 - 199. doi:10.1038/ng0296-195
    • Brandner S, Isenmann S, Raeber A, Fischer M, Sailer A, Kobayashi Y, Marino S, Weissmann C, Aguzzi A (1996). Normal host prion protein necessary for scrapie-induced neurotoxicity.. Nature, 379(6563), 339 - 343. doi:10.1038/379339a0
    • Müller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rülicke T, Brandner S, Aguzzi A, Weissman C (1996). Mice homozygous for a modified beta-amyloid precursor protein (beta APP) gene show impaired behavior and high incidence of agenesis of the corpus callosum.. Ann N Y Acad Sci, 777, 65 - 73.
    • Hassler W, Brandner S, Slansky I (1996). Microsurgical management of lateral lumbar disc herniations: combined lateral and interlaminar approach.. Acta Neurochir (Wien), 138(8), 907 - 910.
    • Aguzzi A, Blattler T, Klein M, Raber A, Weissmann C, Brandner S (1996). Telencephalic brain grafts in the study of scrapie pathogenesis.
    • Isenmann S, Brandner S, Sure U, Aguzzi A (1996). Telencephalic transplants in mice: characterization of growth and differentiation patterns.. Neuropathol Appl Neurobiol, 22(2), 108 - 117.
    • Fritschy JM, Brandner S, Aguzzi A, Koedood M, Luscher B, Mitchell PJ (1996). Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice.. J Neurosci, 16(7), 2275 - 2282.
    • Weissmann C, Fischer M, Raeber A, Büeler H, Sailer A, Shmerling D, Rülicke T, Brandner S, Aguzzi A (1996). The use of transgenic mice in the investigation of transmissible spongiform encephalopathies.. Int J Exp Pathol, 77(6), 283 - 293.
    • Brandner S, Raeber A, Sailer A, Blättler T, Fischer M, Weissmann C, Aguzzi A (1996). Normal host prion protein (PrPC) is required for scrapie spread within the central nervous system.. Proc Natl Acad Sci U S A, 93(23), 13148 - 13151.
    • Weissmann C, Fischer M, Raeber A, Büeler H, Sailer A, Shmerling D, Rülicke T, Brandner S, Aguzzi A (1996). The role of PrP in pathogenesis of experimental scrapie.. Cold Spring Harb Symp Quant Biol, 61, 511 - 522.

    1995

    • Sure U, Bertalanffy H, Isenmann S, Brandner S, Berghorn WJ, Seeger W, Aguzzi A (1995). Secondary manifestation of medulloblastoma: metastases and local recurrences in 66 patients.. Acta Neurochir (Wien), 136(3-4), 117 - 126.
    • Strommer KN, Brandner S, Sarioglu AC, Sure U, Yonekawa Y (1995). Symptomatic cerebellar metastasis and late local recurrence of a cauda equina paraganglioma. Case report.. J Neurosurg, 83(1), 166 - 169. doi:10.3171/jns.1995.83.1.0166
    • Marino S, Kretschmer C, Brandner S, Cavard C, Zider A, Briand P, Isenmann S, Wagner EF, Aguzzi A (1995). Activation of HIV transcription by human foamy virus in transgenic mice.. Lab Invest, 73(1), 103 - 110.
    • Aguzzi A, Brandner S, Isenmann S, Steinbach JP, Sure U (1995). Transgenic and gene disruption techniques in the study of neurocarcinogenesis.. Glia, 15(3), 348 - 364. doi:10.1002/glia.440150314
    • Kraus JA, Koopmann J, Kaskel P, Maintz D, Brandner S, Schramm J, Louis DN, Wiestler OD, von Deimling A (1995). Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytoma.. J Neuropathol Exp Neurol, 54(1), 91 - 95.
    • Isenmann S, Molthagen M, Brandner S, Bartsch U, Kühne G, Magyar JP, Sure U, Schachner M, Aguzzi A (1995). The AMOG/beta 2 subunit of Na,K-ATPase is not necessary for long-term survival of telencephalic grafts.. Glia, 15(4), 377 - 388. doi:10.1002/glia.440150403

    1994

    • Aguzzi A, Brandner S, Sure U, Rüedi D, Isenmann S (1994). Transgenic and knock-out mice: models of neurological disease.. Brain Pathol, 4(1), 3 - 20.
    • ISENMANN S, BRANDNER S, SURE U, MAGYAR JP, SCHACHNER M, AGUZZI A (1994). MORPHOLOGY AND DEVELOPMENT OF NEURAL TRANSPLANTS DEFICIENT OF AMOG.
    • BRANDNER S, HEISS E, GEHRKE G (1994). GLIOBLASTOMA PENETRATING THE ANTERIOR SKULL BASE - CASE REPORT AND REVIEW OF THE LITERATURE.
    • Isenmann S, Brandner S, Sure U, Magyar JP, Schachner M, Aguzzi A (1994). [Morphology and development of neural transplants of AMOG-deficient mice].. Verh Dtsch Ges Pathol, 78, 433 - 437.
    • Albrecht S, von Deimling A, Pietsch T, Giangaspero F, Brandner S, Kleihues P, Wiestler OD (1994). Microsatellite analysis of loss of heterozygosity on chromosomes 9q, 11p and 17p in medulloblastomas.. Neuropathol Appl Neurobiol, 20(1), 74 - 81.
    • SURE U, BERGHORN W, BRANDNER S, ISENMANN S, BERTALANFFY H (1994). MEDULLOBLASTOMA - METASTASES AND LOCAL RECURRENCES. J NEUROSURG, 80(2), A398 - A398.
    • Marino S, Brandner S (1994). Molecular analysis of development and neoplasia: homologous recombination and knock-out approaches, Schloss Reisenburg, Germany, March 22nd, 1994.. Brain Pathol, 4(3), 285 - 286.
    • Müller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, Rülicke T, Brandner S, Aguzzi A, Weissmann C (1994). Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene.. Cell, 79(5), 755 - 765.

    1991

    • Redies H, Brandner S (1991). Functional organization of the auditory thalamus in the guinea pig.. Exp Brain Res, 86(2), 384 - 392.

    1990

    • Brandner S, Redies H (1990). The projection from medial geniculate to field AI in cat: organization in the isofrequency dimension.. J Neurosci, 10(1), 50 - 61.

    1989

    • Redies H, Brandner S, Creutzfeldt OD (1989). Anatomy of the auditory thalamocortical system of the guinea pig.. J Comp Neurol, 282(4), 489 - 511. doi:10.1002/cne.902820403